Bellevue Group »

West Pharmaceutical Services shares owned by Bellevue Group

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $171k 520 329.39
2024-03-31 $344k 870 395.71

More positions owned by Bellevue Group

Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Alnylam Pharmaceuticals (ALNY)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Boston Scientific Corporation (BSX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Intra Cellular Therapies (ITCI)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
UnitedHealth (UNH)
Moderna (MRNA)

View all positions for Bellevue Group

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
BlackRock
Bank of New York Mellon
State Street Corporation
Artisan Partners Limited Partnership
Franklin Resources
Alliancebernstein
Brown Advisory Holdings Incorporated
Geode Capital Management
T. Rowe Price Associates
Durable Capital Partners
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Findlay Park Partners

View all funds holding West Pharmaceutical Services